NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 315 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,650 | -23.5% | 5,500 | 0.0% | 0.00% | – |
| Q2 2023 | $88,385 | -7.7% | 5,500 | 0.0% | 0.00% | – |
| Q1 2023 | $95,755 | +88.4% | 5,500 | 0.0% | 0.00% | – |
| Q4 2022 | $50,820 | +8.1% | 5,500 | 0.0% | 0.00% | – |
| Q3 2022 | $47,000 | +4.4% | 5,500 | 0.0% | 0.00% | – |
| Q2 2022 | $45,000 | -32.8% | 5,500 | -0.2% | 0.00% | – |
| Q1 2022 | $67,000 | -64.4% | 5,513 | +0.2% | 0.00% | – |
| Q4 2021 | $188,000 | -29.1% | 5,500 | 0.0% | 0.00% | – |
| Q3 2021 | $265,000 | +6.9% | 5,500 | 0.0% | 0.00% | – |
| Q2 2021 | $248,000 | -6.4% | 5,500 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $265,000 | -10.5% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $296,000 | +45.8% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $203,000 | +19.4% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $170,000 | +11.8% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $152,000 | -5.6% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $161,000 | +53.3% | 5,500 | 0.0% | 0.00% | – |
| Q3 2019 | $105,000 | -15.3% | 5,500 | -2.4% | 0.00% | – |
| Q2 2019 | $124,000 | +8.8% | 5,633 | +1.2% | 0.00% | – |
| Q1 2019 | $114,000 | +65.2% | 5,566 | +1.2% | 0.00% | – |
| Q4 2018 | $69,000 | -17.9% | 5,500 | 0.0% | 0.00% | – |
| Q3 2018 | $84,000 | +16.7% | 5,500 | 0.0% | 0.00% | – |
| Q2 2018 | $72,000 | +60.0% | 5,500 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | -8.2% | 5,500 | 0.0% | 0.00% | – |
| Q4 2017 | $49,000 | -19.7% | 5,500 | 0.0% | 0.00% | – |
| Q3 2017 | $61,000 | +7.0% | 5,500 | -14.2% | 0.00% | – |
| Q2 2017 | $57,000 | +32.6% | 6,407 | +16.5% | 0.00% | – |
| Q1 2017 | $43,000 | -41.1% | 5,500 | -35.2% | 0.00% | -100.0% |
| Q4 2016 | $73,000 | -3.9% | 8,487 | -10.0% | 0.00% | 0.0% |
| Q2 2016 | $76,000 | +18.8% | 9,430 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $64,000 | -13.5% | 9,430 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $74,000 | +37.0% | 9,430 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $54,000 | – | 9,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |